My account
Injectables Orals Peptides Human Growth Hormone SARMs
Sign in
A
Anastrozole
B
Bacteriostatic water Boldenone undecylenate
C
Clenbuterol Clomiphene citrate Cabergoline
D
Drostanolone enanthate Drostanolone propionate Dehydroepiandrosterone (DHEA)
E
Erythropoietin Exemestane
F
Fluoxymesterone
H
Human chorionic gonadotropin Human growth hormone
L
Liothyronine sodium
M
Mecasermin Meldonium Mesterolone Methandienone Methenolone acetate Methenolone enanthate Melanotan-2
N
Nandrolone decanoate Nandrolone phenylpropionate
O
Oxandrolone Oxymetholone
S
Sildenafil citrate Stanozolol
T
Trenbolone enanthate Trestolone acetate Trenbolone acetate Testosterone undecanoate Testosterone propionate Testosterone base and suspension Tadalafil citrate Testosterone cypionate Testosterone enanthate Tamoxifen citrate Turinabol
Y
Yohimbine
Show 164 results
Manufacturers
Categories
Substances
Disagree
Home Swiss Remedies Swiss Remedies
Amifostine Crystalline 500 AMPULES
Amifostine Crystalline 500 AMPULES - Swiss Remedies

Amifostine Crystalline 500 AMPULES - Swiss Remedies

Brand:
Swiss Remedies
Category:
Injectables
Substance:
Amifostine
Dosage:
500 mg/ml
Package:
10 ml
Price:
0
See options
Product Overview

Known for its antioxidant properties, amifostine has emerged as a promising candidate for treating IPF. It combats fibrosis by reducing mitochondrial ROS, restoring oxidative phosphorylation, and rebalancing energy metabolism. By activating SIRT1 and AMPK, it helps maintain mitochondrial function and cellular health. These effects position amifostine as a potential therapy to slow IPF progression and improve patient outcomes.

References:

Guo, F., Xu, F., Li, S., Zhang, Y., Lv, D., Zheng, L., Gan, Y., Zhou, M., Zhao, K., Xu, S., Wu, B., Deng, Z. and Fu, P., 2024. Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD+/SIRT1/AMPK pathway-mediated effects on mitochondrial function and cellular metabolism. European Journal of Medical Research

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Amifostine Crystalline 500 AMPULES by Swiss Remedies, consult with your doctor or healthcare professional.

Explore More Products
Reviews
Leave Review
FAQ
Is amifostine FDA-approved for IPF treatment?
No, it is not yet approved for IPF but shows promising results in preclinical studies as a potential therapeutic option.
References:

Guo, F., Xu, F., Li, S., Zhang, Y., Lv, D., Zheng, L., Gan, Y., Zhou, M., Zhao, K., Xu, S., Wu, B., Deng, Z. and Fu, P., 2024. Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD+/SIRT1/AMPK pathway-mediated effects on mitochondrial function and cellular metabolism. European Journal of Medical Research

What are the common side effects of amifostine?
Side effects may include nausea, vomiting, low blood pressure, and allergic reactions, typically associated with its use in cancer treatment.
References:

Guo, F., Xu, F., Li, S., Zhang, Y., Lv, D., Zheng, L., Gan, Y., Zhou, M., Zhao, K., Xu, S., Wu, B., Deng, Z. and Fu, P., 2024. Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD+/SIRT1/AMPK pathway-mediated effects on mitochondrial function and cellular metabolism. European Journal of Medical Research

How is amifostine administered?
It is commonly given via intravenous or intraperitoneal injection, depending on the treatment setting and condition being addressed.
References:

Guo, F., Xu, F., Li, S., Zhang, Y., Lv, D., Zheng, L., Gan, Y., Zhou, M., Zhao, K., Xu, S., Wu, B., Deng, Z. and Fu, P., 2024. Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD+/SIRT1/AMPK pathway-mediated effects on mitochondrial function and cellular metabolism. European Journal of Medical Research